Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting
Crossref DOI link: https://doi.org/10.1007/s13300-019-00725-9
Published Online: 2019-12-05
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Melzer-Cohen, Cheli
Chodick, Gabriel
Naftelberg, Shiran
Shehadeh, Naim
Karasik, Avraham
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 4 October 2019
First Online: 5 December 2019